Related references
Note: Only part of the references are listed.Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis
Yu Pei Chock et al.
AUTOIMMUNITY REVIEWS (2019)
Thrombocytopenia in high-risk patients with antiphospholipid syndrome
E. Pontara et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity
C. M. Yelnik et al.
LUPUS (2017)
Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study
R. Hisada et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Pregnancy failure in patients with obstetric antiphospholipid syndrome with conventional treatment: the influence of a triple positive antibody profile
J. O. Latino et al.
LUPUS (2017)
Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies
Laurent Arnaud et al.
AUTOIMMUNITY REVIEWS (2015)
Related factors of fetal loss in Chinese women with systemic lupus erythematosus: data from Chinese SLE Treatment and Research Group registry IV
Xinping Tian et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2015)
Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS
Valerie Proulle et al.
BLOOD (2014)
The relationship between mean platelet volume and thrombosis recurrence in patients diagnosed with antiphospholipid syndrome
Joanna Rupa-Matysek et al.
RHEUMATOLOGY INTERNATIONAL (2014)
Non-criteria manifestations of antiphospholipid syndrome
D. Erkan et al.
LUPUS (2010)
Share Paper
